What Should Specialty Pharmacists Know About the REVERCE Clinical Trial?

Article
Conference|Gastrointestinal Cancers Symposium

Kohei Shitara, MD, Department of Gastrointestinal Oncology of National Cancer Center Hospital East, Japan, discusses the importance of the REVERCE clinical trial for specialty pharmacists.

Related Videos
Laboratory test tubes and solution with stethoscope background | Image Credit: Shutter2U - stock.adobe.com
Image credit: Krakenimages.com | stock.adobe.com
Human brain digital illustration. Electrical activity, flashes, and lightning on a blue background. | Image Credit: Siarhei - stock.adobe.com
3D illustration of heart
Model of a heart
Man experiencing heart pain
3D illustration of heart
Related Content
Image credit: Tada Images | stock.adobe.com

FDA Offers Priority Review to Enfortumab Vedotin-Ejfv, Pembrolizumab Combination for Metastatic Bladder Cancer

December 1st 2023
Article
Independent Rx Forum - NCPA Conference: Legal Update on PBM Litigation

Independent Rx Forum - NCPA Conference: Legal Update on PBM Litigation

October 24th 2023
Podcast
Amyloid plaques in Alzheimer's disease | Image Credit: Artur - stock.adobe.com

Study: Cholesterol in Brain Associated Alzheimer Disease, Brain Damage

December 1st 2023
Article
Pharmacy Focus: Oncology Edition- A Practical, Real-World Understanding of the Enhancing Oncology Model

Pharmacy Focus: Oncology Edition- A Practical, Real-World Understanding of the Enhancing Oncology Model

October 17th 2023
Podcast
Neurons cells concept | Image Credit: whitehoune - stock.adobe.com

FDA Issues Warning Of Antiseizure Medications Causing Rare, Serious Reactions

November 30th 2023
Article
Image credit: wladimir1804 | stock.adobe.com

FDA Grants Orphan Drug Designation to KRP203 Following allo-HSCT in Patients with Hematologic Malignancies

November 30th 2023
Article
© 2023 MJH Life Sciences

All rights reserved.